Quality Assurance

QUALITY ASSURANCE

Smart Manufacturing

● The construction of the three-phase project has resulted in a diversified product portfolio covering both human and veterinary pharmaceuticals, backed by scalable production capabilities. 1. Phase I has established production capacities for vitamin D series, plant extracts, and 50,000 tons of traditional Chinese medicine granules. 2. Phase II secured veterinary drug manufacturing qualifications and successfully commercialized 20 veterinary drug formulations. 3. Phase III focuses on chemical active pharmaceutical ingredients (APIs), establishing production lines for lidocaine, dehydrocholesterol, and other key products, creating a comprehensive product portfolio with notably robust production capacity.
Smart Manufacturing

Extract Workshop Production Site 2
Extract Production Site Workshop 1
Chemical Synthesis Workshop Production Site 2